Identification of factors associated with duplicate rate in ChIP-seq data.

by Shulan Tian, Shuxia Peng, Michael Kalmbach, Krutika S Gaonkar, Aditya Bhagwate, Wei Ding, Jeanette Eckel-Passow, Huihuang Yan, Susan L Slager
Published 2019-01-01

Prevalence and the impact of hypogammaglobulinemia in newly diagnosed chronic lymphocytic lymphoma patients

by Namrata Singh, Sarah L. Mott, Grerk Sutamtewagul, Ashley McCarthy, Susan L. Slager, James R. Cerhan, Zuhair Ballas, Brian K. Link
Published 2020-11-01

Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample.

by Eric J Peters, Susan L Slager, Jeffrey B Kraft, Greg D Jenkins, Megan S Reinalda, Patrick J McGrath, Steven P Hamilton
Published 2008-04-01

Renal insufficiency is an independent prognostic factor in patients with chronic lymphocytic leukemia

by Paolo Strati, Kari G. Chaffee, Sara J. Achenbach, Susan L. Slager, Nelson Leung, Timothy G. Call, Wei Ding, Sameer A. Parikh, Neil E Kay, Tait D. Shanafelt
Published 2017-01-01

Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomes

by Sameer A. Parikh, Kari G. Rabe, Neil E. Kay, Timothy G. Call, Wei Ding, Susan M. Schwager, Deborah A. Bowen, Michael Conte, Diane F. Jelinek, Susan L. Slager, Tait D. Shanafelt
Published 2014-01-01

Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota

by Geffen Kleinstern, Dirk R. Larson, Cristine Allmer, Aaron D. Norman, Grace Muntifering, Jason Sinnwell, Alissa Visram, Vincent Rajkumar, Angela Dispenzieri, Robert A. Kyle, Susan L. Slager, Shaji Kumar, Celine M. Vachon
Published 2022-04-01

Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemia

by Shulan Tian, Henan Zhang, Pan Zhang, Michael Kalmbach, Jeong-Heon Lee, Tamas Ordog, Paul J. Hampel, Timothy G. Call, Thomas E. Witzig, Neil E. Kay, Eric W. Klee, Susan L. Slager, Huihuang Yan, Wei Ding
Published 2021-04-01

B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells

by Zhiquan Wang, Huihuang Yan, Justin C. Boysen, Charla R. Secreto, Renee C. Tschumper, Dania Ali, Qianqian Guo, Jian Zhong, Jiaqi Zhou, Haiyun Gan, Chuanhe Yu, Diane F. Jelinek, Susan L. Slager, Sameer A. Parikh, Esteban Braggio, Neil E. Kay
Published 2022-07-01

Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center

by Yucai Wang, Marcella A. Tschautscher, Kari G. Rabe, Timothy G. Call, Jose F. Leis, Saad S. Kenderian, Neil E. Kay, Eli Muchtar, Daniel L. Van Dyke, Amber B. Koehler, Susan M. Schwager, Susan L. Slager, Sameer A. Parikh, Wei Ding
Published 2020-03-01

Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era

by Cristina Correia, Matthew J. Maurer, Samantha J. McDonough, Paula A. Schneider, Paige E. Ross, Anne J. Novak, Andrew L. Feldman, James R. Cerhan, Susan L. Slager, Thomas E. Witzig, Bruce W. Eckloff, Hu Li, Grzegorz S. Nowakowski, Scott H. Kaufmann
Published 2023-05-01

The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosis

by Sameer A. Parikh, Sara J. Achenbach, Kari G. Rabe, Aaron D. Norman, Nicholas J. Boddicker, Janet E. Olson, Timothy G. Call, James R. Cerhan, Celine M. Vachon, Neil E. Kay, Esteban Braggio, Curtis A. Hanson, Susan L. Slager, Tait D. Shanafelt
Published 2022-11-01

Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index

by Yucai Wang, Sara J. Achenbach, Kari G. Rabe, Tait D. Shanafelt, Timothy G. Call, Wei Ding, Saad S. Kenderian, Eli Muchtar, Jose F. Leis, Amber B. Koehler, Susan M. Schwager, James R. Cerhan, Susan L. Slager, Neil E. Kay, Sameer A. Parikh
Published 2021-08-01

Outcomes among North American patients with diffuse large B-cell lymphoma are independent of tumor Epstein-Barr virus positivity or immunosuppression

by Sean I. Tracy, Thomas M. Habermann, Andrew L. Feldman, Matthew J. Maurer, Ahmet Dogan, Usha S. Perepu, Sergei Syrbu, Stephen M. Ansell, Carrie A. Thompson, George J. Weiner, Grzegorz S. Nowakowski, Cristine Allmer, Susan L. Slager, Thomas E. Witzig, James R. Cerhan, Brian K. Link
Published 2018-02-01

Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis

by Sameer A. Parikh, Kari G. Chaffee, Melissa C. Larson, Paul J. Hampel, Timothy G. Call, Wei Ding, Saad S. Kenderian, Jose F. Leis, Asher A. Chanan-Khan, Michael J. Conte, Deborah Bowen, Susan M. Schwager, Susan L. Slager, Curtis A. Hanson, Neil E. Kay, Tait D. Shanafelt
Published 2018-06-01

Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome

by Yucai Wang, Sutapa Sinha, Linda E. Wellik, Charla R. Secreto, Karen L. Rech, Timothy G. Call, Sameer A. Parikh, Saad S. Kenderian, Eli Muchtar, Suzanne R. Hayman, Amber B. Koehler, Daniel L. Van Dyke, Jose F. Leis, Susan L. Slager, Haidong Dong, Neil E. Kay, Rong He, Wei Ding
Published 2021-05-01

The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor

by Yucai Wang, Kari G. Rabe, Michael S. Bold, Min Shi, Curtis A. Hanson, Susan M. Schwager, Timothy G. Call, Saad S. Kenderian, Eli Muchtar, Suzanne R. Hayman, Amber B. Koehler, Amie L. Fonder, Asher A. Chanan-Khan, Daniel L. Van Dyke, Susan L. Slager, Neil E. Kay, Wei Ding, Jose F. Leis, Sameer A. Parikh
Published 2020-01-01

Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?

by Rebecca L. King, Alia Gupta, Paul J. Kurtin, Wei Ding, Timothy G. Call, Kari G. Rabe, Saad S. Kenderian, Jose F. Leis, Yucai Wang, Susan M. Schwager, Susan L. Slager, Neil. E. Kay, Amber Koehler, Stephen M. Ansell, David J. Inwards, Thomas M. Habermann, Min Shi, Curtis A. Hanson, Matthew T. Howard, Sameer A. Parikh
Published 2022-01-01

Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia

by Paul J. Hampel, Sameer A. Parikh, Timothy G. Call, Mithun V. Shah, N. Nora Bennani, Aref Al-Kali, Kari G. Rabe, Yucai Wang, Eli Muchtar, Jose F. Leis, Saad S. Kenderian, Amber B. Koehler, Susan M. Schwager, Susan L. Slager, Neil E. Kay, Curtis A. Hanson, Daniel L. Van Dyke, Min Shi, Wei Ding
Published 2021-03-01

The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice

by Sameer A. Parikh, Sara J. Achenbach, Timothy G. Call, Kari G. Rabe, Wei Ding, Jose F. Leis, Saad S. Kenderian, Asher A. Chanan‐Khan, Amber B. Koehler, Susan M. Schwager, Eli Muchtar, Amie L. Fonder, Kristen B. McCullough, Adrienne N. Nedved, Matthew D. Smith, Susan L. Slager, Neil E. Kay, Heidi D. Finnes, Tait D. Shanafelt
Published 2020-05-01

Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib

by Paul J. Hampel, Kari G. Rabe, Timothy G. Call, Wei Ding, Jose F. Leis, Asher A. Chanan-Khan, Saad S. Kenderian, Eli Muchtar, Yucai Wang, Sikander Ailawadhi, Amber B. Koehler, Ricardo Parrondo, Susan M. Schwager, Taimur Sher, Curtis A. Hanson, Min Shi, Daniel L. Van Dyke, Esteban Braggio, Susan L. Slager, Neil E. Kay, Sameer A. Parikh
Published 2022-09-01